You have 9 free searches left this month | for more free features.

gemfibrozil

Showing 26 - 50 of 61

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Functional Dyspepsia - Clinical Response to Montelukast in

Completed
  • Eosinophilia
  • Dyspepsia
    • Kansas City, Missouri
      Children's Mercy
    May 15, 2019

    Healthy Volunteers Trial run by the CC (Lopinavir/Ritonavir, Gemfibrozil)

    Completed
    • Healthy Volunteers
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Sep 23, 2016

    Healthy Trial in Tempe (JNJ-56021927, Itraconazole, Gemfibrozil)

    Completed
    • Healthy
    • Tempe, Arizona
      (unnamed)
    Oct 19, 2016

    Diabetic Nephropathy Trial in Minneapolis (Lisinopril, Nifedipine, Simvastatin)

    Completed
    • Diabetic Nephropathy
    • Minneapolis, Minnesota
      Hennepin County Medical Center
    Mar 5, 2018

    Healthy Subjects Trial in Kiel (Selexipag, Gemfibrozil, Rifampicin)

    Completed
    • Healthy Subjects
    • Kiel, Germany
      Investigator Site
    Jul 20, 2016

    Dyslipidemias, Cardiovascular Risk Factor Trial in Mexico City (L-Carnitine 500Mg Oral Tablet + Atorvastatin 10 mg, Atorvastatin

    Unknown status
    • Dyslipidemias
    • Cardiovascular Risk Factor
    • L-Carnitine 500Mg Oral Tablet + Atorvastatin 10 mg
    • Atorvastatin 10mg
    • Mexico City, Mexico
      Laboratorios Grossman Sa
    Feb 25, 2019

    PGC-1 & MUSCLE MITOCHONDRIAL DYSFUNCTION IN DIABETES: AIMS 1-4

    Unknown status
    • Type2 Diabetes
    • Obesity
      • Tucson, Arizona
        The University of Arizona
      Oct 24, 2017

      Cardiovascular Diseases, Coronary Disease, Heart Diseases Trial (pravastatin, niacin, cholestyramine)

      Completed
      • Cardiovascular Diseases
      • +3 more
      • (no location specified)
      Mar 15, 2016

      Burns Trial in Nashville (Rosuvastatin, Placebo)

      Completed
      • Burns
      • Nashville, Tennessee
        Vanderbilt University Medical Center
      Apr 25, 2018

      Coronary Heart Disease Trial in Minneapolis (gemfibrozil, Placebo)

      Completed
      • Coronary Heart Disease
      • gemfibrozil
      • Placebo
      • Minneapolis, Minnesota
        Minneapolis VA Health Care System, Minneapolis, MN
      Oct 20, 2015

      Diabetes, Type 2, Kidney Failure, Chronic, Hyperlipidemia Trial in Miami (Extended release niacin, Placebo)

      Terminated
      • Diabetes Mellitus, Type 2
      • +2 more
      • Extended release niacin
      • Placebo
      • Miami, Florida
        Univesity of Miami/Diabetes Research Institute
      May 17, 2016

      VA HDL Intervention Trial (VA-HIT) Ancillary Study Data Analysis

      Completed
      • Coronary Disease
      • +8 more
        • (no location specified)
        Mar 15, 2016

        Atrial Fibrillation Trial in São Paulo (Marevan®, generic warfarin #1, generic warfarin #2)

        Completed
        • Atrial Fibrillation
        • São Paulo, Brazil
          Hospital São Paulo/Hospital Universitário da UNIFESP (University
        Nov 21, 2016

        Diabetes, Obesity Trial in Scottsdale (Pre-study dietary and exercise instruction., Screening examination and oral glucose

        Terminated
        • Diabetes
        • Obesity
        • Pre-study dietary and exercise instruction.
        • +5 more
        • Scottsdale, Arizona
          Mayo Clinic
        May 10, 2016

        Effects of CHD Prevention on Lipoprotein Subclasses

        Completed
        • Cardiovascular Diseases
        • +2 more
          • (no location specified)
          Feb 26, 2016

          Healthy Trial in Biberach (BI 10773, Gemfibrozil)

          Completed
          • Healthy
          • BI 10773
          • Gemfibrozil
          • Biberach, Germany
            1245.58.1 Boehringer Ingelheim Investigational Site
          May 16, 2014

          Cardiovascular Diseases, Heart Diseases, Cerebrovascular Accident Trial in Canada, United States (Extended release niacin,

          Terminated
          • Cardiovascular Diseases
          • +5 more
          • Birmingham, Alabama
          • +90 more
          Mar 8, 2016

          Bioavailability Trial (Gemfibrozil Tablets)

          Completed
          • Bioavailability
          • Gemfibrozil Tablets
          • (no location specified)
          Aug 9, 2013

          High Density Lipoprotein Subspecies and Coronary Disease

          Completed
          • Cardiovascular Diseases
          • +3 more
            • (no location specified)
            Mar 3, 2014

            Drug-Drug Interaction (DDI), Healthy Subjects Trial in Harrow (ASP3652, Gemfibrozil, Repaglinide)

            Completed
            • Drug-Drug Interaction (DDI)
            • Healthy Subjects
            • Harrow, United Kingdom
              PAREXEL Early Phase Clinical Unit
            Feb 20, 2013

            Hypertriglyceridemia in Type 4 Hyperlipidemia, Non Diabetic Subjects With Normoglycemia Trial in San Antonio (Rosiglitazone,

            Terminated
            • Hypertriglyceridemia in Type 4 Hyperlipidemia
            • Non Diabetic Subjects With Normoglycemia
            • San Antonio, Texas
              Brooke Army Medical Center
            Apr 8, 2014

            Healthy Subjects Trial in Taipei (Gemfibrozil & red yeast rice (LipoCol))

            Completed
            • Healthy Subjects
            • Gemfibrozil & red yeast rice (LipoCol)
            • Taipei, Taiwan
              National Taiwan University Hospital
            Oct 13, 2011

            Pharmacoepidemiology and Pharmacogenetics ofStatin Adverse Event

            Completed
            • Rhabdomyolysis
              • Seattle, Washington
                University of Washington
              Jan 4, 2012

              Carnitine Palmitoyltransferase II Deficiency, Very Long Chain Acyl Coa Dehydrogenase Deficiency Trial in Copenhagen

              Completed
              • Carnitine Palmitoyltransferase II Deficiency
              • Very Long Chain Acyl Coa Dehydrogenase Deficiency
              • Copenhagen, Denmark
                Neuromusculare Research Unit, Rigshospitalet
              May 29, 2012